Nevertheless, important strengths of our study include its novelty, being the first to analyze the B cell phenotype dynamics as a response to CHMI in individuals with different immunity and hb status, as well as the analysis of B cell surface markers not previously studied in the context of malaria such as CD1c. This evidence concerns the gene CD1C and malaria.